41
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Clinical experience with atypical antipsychotics in an acute inpatient unit: focus on quetiapine

, , , , , & show all
Pages 138-141 | Received 28 Jun 2005, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Koh Ong Hui, Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Subash Kumar Pillai, Stephen Thevanathan Jambunathan & Rusdi Abdul Rashid. (2013) A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Extended Release Quetiapine Fumarate in the Treatment of Agitation in Patients with Schizophrenia. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 23:1, pages 14-23.
Read now
J. Peuskens, J.M. Devoitille, J. Kusters & G. Vandenhoven. (2008) An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder. International Journal of Psychiatry in Clinical Practice 12:4, pages 261-267.
Read now
Jane Stein-Parbury, Kim Reid, Narelle Smith, Diane Mouhanna & Fiona Lamont. (2008) Use of pro re nata medications in acute inpatient care. Australian and New Zealand Journal of Psychiatry 42:4, pages 283-292.
Read now
Joseph Peuskens, Siegfried Kasper, Celso Arango, Pier Luca Bandinelli, Markus Gastpar, Nicholas Keks, Sheena Mitchell, Timuçin Oral, Kristina Timdahl & Eduard Vieta. (2007) Management of acutely ill patients in the hospital setting: focus on quetiapine. International Journal of Psychiatry in Clinical Practice 11:1, pages 61-72.
Read now

Articles from other publishers (7)

Pei-Yin Pan, Meei-Shyuan Lee & Chin-Bin Yeh. (2015) The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population. BMC Psychiatry 15:1.
Crossref
Laila Asmal, Srnka J Flegar, Jikun Wang, Christine Rummel-Kluge, Katja Komossa & Stefan Leucht. (2013) Quetiapine versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Cheng‐Cheng Hsiao, Kun‐Po Chen, Chang‐Jer Tsai, Liang‐Jen Wang, Chih‐Ken Chen & Shih‐Ku Lin. (2011) Rapid initiation of quetiapine well tolerated as compared with the conventional initiation regimen in patients with schizophrenia or schizoaffective disorders. The Kaohsiung Journal of Medical Sciences 27:11, pages 508-513.
Crossref
Katja Komossa, Christine Rummel-Kluge, Sandra Schwarz, Franziska Schmid, Heike Hunger, Werner Kissling & Stefan Leucht. (2011) Risperidone versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Lorna Duggan, Werner Kissling & Stefan Leucht. (2010) Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Katja Komossa, Christine Rummel-Kluge, Franziska Schmid, Heike Hunger, Sandra Schwarz, Manit Srisurapanont, Werner Kissling & Stefan Leucht. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Giuseppina Boidi & Maurizio Ferro. (2007) Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel‐group, open study. Human Psychopharmacology: Clinical and Experimental 22:5, pages 299-306.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.